Insider Stock Trading History of Briner Kurt W


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Briner Kurt W since year 2005. The trader's CIK number is 1250264. At the time of this reporting, Briner Kurt W is the Director of Bioamber Inc. . (stock ticker symbol BIOA.U). See this page for all insider trading activities at Bioamber Inc. .

Note that in the past BRINER KURT W also reported insider trading activities as an insider of the following companies:
Stock purchases, sales, and option exercises reported by insider Briner Kurt W since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2017-08-15 BIOA Bioamber Inc. Buy 133,333 .00 0
2016-11-08 BIOA Bioamber Inc. Buy 10,000 3.84 38,420
2016-05-24 BIOA Bioamber Inc. Buy 1,000 3.69 3,691
2016-05-23 BIOA Bioamber Inc. Buy 8,915 3.70 32,976
2016-05-20 BIOA Bioamber Inc. Buy 12,100 3.54 42,785
2015-08-06 BIOA Bioamber Inc. Buy 40,000 5.99 239,480
2015-05-06 BIOA Bioamber Inc. Buy 10,000 9.00 90,000
2014-11-10 BIOA Bioamber Inc. Buy 15,000 9.26 138,930
2014-09-09 BIOA Bioamber Inc. Buy 5,000 12.00 60,000
2014-08-22 BIOA Bioamber Inc. Buy 100 11.50 1,150
2014-08-25 BIOA Bioamber Inc. Buy 14,150 11.50 162,725
2014-08-12 BIOA Bioamber Inc. Buy 200 11.50 2,300
2014-08-11 BIOA Bioamber Inc. Buy 2,980 11.40 33,986
2013-11-14 BIOA Bioamber Inc. Buy 7,200 6.95 50,040
2013-08-15 BIOA Bioamber Inc. Buy 13,000 5.49 71,370
2013-05-23 BIOA.U Bioamber Inc. Buy 6,000 .00 0
2013-05-22 BIOA.U Bioamber Inc. Buy 7,000 .00 0
2012-02-03 PGNX Progenics Pharmaceuticals Inc Sale 33,000 10.22 337,227
2011-05-13 PGNX Progenics Pharmaceuticals Inc Sale 15,000 8.27 123,975
2011-05-16 PGNX Progenics Pharmaceuticals Inc Sale 5,000 8.19 40,925
2008-08-28 PGNX Progenics Pharmaceuticals Inc Option Ex 50,000 9.62 481,250

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Briner Kurt W (Director of Bioamber Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.